Том 1 № 1 (2015) | Research Results in Pharmacology

Экспериментальная фармакология

Concomitant use of statins and s-(2-boron-ethyl)-l-cysteine arginase inhibitor to correct endotoxin-induced endothelial dysfunction

Tatiana Alekseevna Denisyuk, Serghei A. Demchenko, Karen V. Saroyan

3-8
https://doi.org/10.18413/2500-235X-2015-1-4-4-8
30.12.2015 Аннотация: 130 | PDF (English): 48 |
- PDF (English)
Экспериментальная фармакология

Human recombinant erythropoietin gradient dosage influence on ischemic and reperfusion liver injury

S.A. Alehin, D.I. Kolmykov, M.V. Pokrovskii

9-12
https://doi.org/10.18413/2500-235X-2015-1-4-9-14
30.12.2015 Аннотация: 120 | PDF (English): 70 |
- PDF (English)
Экспериментальная фармакология

Use of selective inhibitors of Arginase 2 and Tadalafil in combined compensation of homocysteine-induced endothelial dysfunction

I.S. Koklin

13-19
https://doi.org/10.18413/2500-235X-2015-1-4-15-20
30.12.2015 Аннотация: 123 | PDF (English): 45 |
- PDF (English)
Экспериментальная фармакология

Ion channel TRPA1 is a promising therapeutic target for treatment of pain

E.A. Beskhmelnitsyna, M.V. Korokin, T.V. Avtina, O.V. Martynova, I.I. Varavin, A.N. Tishin

20-22
https://doi.org/10.18413/2500-235X-2015-1-4-21-24
30.12.2015 Аннотация: 120 | PDF (English): 48 |
- PDF (English)
Экспериментальная фармакология

Pharmacological protection of the ischemic myocardium by derivatives of 3-(2,2,2-trimethylhydrazinium) propionate and evaluation of their antioxidant activity

S.Ya. Skachilova, L.M. Danilenko, O.G. Kesarev, I.S. Kochkarova

23-27
https://doi.org/10.18413/2500-235X-2015-1-4-25-31
30.12.2015 Аннотация: 125 | PDF (English): 55 |
- PDF (English)
Экспериментальная фармакология

The study of osteoprotective properties of nanoparticulated forms of resveratrol and losartan

N.Yu Koklina, O.S. Gudyrev, A.V. Faitelson

28-33
https://doi.org/10.18413/2500-235X-2015-1-4-32-38
30.12.2015 Аннотация: 118 | PDF (English): 41 |
- PDF (English)
Экспериментальная фармакология

The effect of humoral factors released by hypoperfused placenta on fetal development

V.V. Gureev, O.Ye. Antseferova, T.I. Lokteva, A.A. Dolzhikov

34-37
https://doi.org/10.18413/2500-235X-2015-1-4-39-44
30.12.2015 Аннотация: 120 | PDF (English): 41 |
- PDF (English)
Экспериментальная фармакология

Properties of nano encapsulated L-arginine and resveratrol in water-soluble polymers

I.A. Bogachev, A.A. Krolevets

38-41
https://doi.org/10.18413/2500-235X-2015-1-4-45-50
30.12.2015 Аннотация: 129 | PDF (English): 39 |
- PDF (English)
Экспериментальная фармакология

Ischemia/reperfusion effect on pancreatic volumetrical blood flow velocity

D.I. Kolmykov, S.A. Alehin

42-46
https://doi.org/10.18413/2500-235X-2015-1-4-51-56
30.12.2015 Аннотация: 117 | PDF (English): 47 |
- PDF (English)
Экспериментальная фармакология

Study of the microcirculation level in bone with osteoporosis and osteoporotic fractures during therapy with recombinant erythropoietin, rosuvastatin and their combinations

D.S.R. Rajkumar, O.S. Gudyrev, A.V. Faitelson, M.V. Pokrovskii

47-50
https://doi.org/10.18413/2500-235X-2015-1-4-57-60
30.12.2015 Аннотация: 155 | PDF (English): 44 |
- PDF (English)
Клиническая фармакология

Assessment of senior dental students and dental residents in matters of antimicrobial chemotherapy

R.A. Bontsevich, K.V. Shchurovskaya, T.G. Pokrovskaya, L.Ye. Goryainova

51-57
https://doi.org/10.18413/2500-235X-2015-1-4-61-68
30.12.2015 Аннотация: 124 | PDF (English): 48 |
- PDF (English)
Клиническая фармакология

Pancreatogenic infections: importance of microbiological monitoring and penetration of antimicrobial chemotherapeutic agents into the pancreas when defining therapeutic approach

O.V. Filippova, T.N. Malorodova, T.G. Pokrovskaya, Yu.I. Afanasiev

58-62
https://doi.org/10.18413/2500-235X-2015-1-4-69-72
30.12.2015 Аннотация: 108 | PDF (English): 37 |
- PDF (English)

Язык